Panelists discuss how to effectively integrate vasomotor symptom (VMS) treatment into comprehensive health management plans for women, taking into account the significant comorbidities associated with ...
By 2008, fewer than 5 percent of women were receiving the treatment. Within a year, the FDA had put a “black box” warning on estrogen products used in hormone therapy—the most serious ...
Until recently, most women who underwent adjuvant hormone therapy to reduce the chance of a breast cancer recurrence took tamoxifen every day for 5 years. However, with the advent of newer hormone ...
(HealthDay News) — Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women, according to a study presented at the ...